Risk communication AC meeting
This article was originally published in The Tan Sheet
Executive SummaryFDA will hold a public meeting of the Risk Communication Advisory Committee on Feb. 28 and 29 at the Washington, D.C. North/Gaithersburg, Md. Hilton, the agency announces in a Feb. 8 Federal Register notice. The committee will meet the first day from 8 a.m. to 5 p.m. for presentations and discussion of the relation of the agency's risk communication programs and FDA's responsibilities. The committee will continue on the second day from 8 a.m. to 4 p.m. with presentations and discussion of FDA's proposed template for product recall press releases, the agency says...
You may also be interested in...
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.
Successfully acquired by Colgate-Palmolive on 31 January, Hello quickly made a statement with the launch of a CBD oral-care range and its first go at lip care, CBD Vegan Lip Balm. Available exclusively through Ulta Beauty, the CBD products have the potential to score well with younger consumers interested in natural ingredients, eco-friendly packaging and, of course, cannabis-based innovations.
A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.